Literature DB >> 17646391

Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation.

Larbi Amazit1, Luigi Pasini, Adam T Szafran, Valeria Berno, Ray-Chang Wu, Marylin Mielke, Elizabeth D Jones, Maureen G Mancini, Cruz A Hinojos, Bert W O'Malley, Michael A Mancini.   

Abstract

The steroid receptor coactivator 3 gene (SRC-3) (AIB1/ACTR/pCIP/RAC3/TRAM1) is a p160 family transcription coactivator and a known oncogene. Despite its importance, the functional regulation of SRC-3 remains poorly understood within a cellular context. Using a novel combination of live-cell, high-throughput, and fluorescent microscopy, we report SRC-3 to be a nucleocytoplasmic shuttling protein whose intracellular mobility, solubility, and cellular localization are regulated by phosphorylation and estrogen receptor alpha (ERalpha) interactions. We show that both chemical inhibition and small interfering RNA reduction of the mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 (MEK1/2) pathway induce a cytoplasmic shift in SRC-3 localization, whereas stimulation by epidermal growth factor signaling enhances its nuclear localization by inducing phosphorylation at T24, S857, and S860, known participants in the phosphocode that regulates SRC-3 activity. Accordingly, the cytoplasmic localization of a nonphosphorylatable SRC-3 mutant further supported these results. In the presence of ERalpha, U0126 also dramatically reduces (i) ligand-dependent colocalization of SRC-3 and ERalpha, (ii) the formation of ER-SRC-3 complexes in cell lysates, and (iii) SRC-3 targeting to a visible, ERalpha-occupied and -regulated prolactin promoter array. Taken together, these results indicate that phosphorylation coordinates SRC-3 coactivator function by linking the probabilistic formation of transient nuclear receptor-coactivator complexes with its molecular dynamics and cellular compartmentalization. Technically and conceptually, these findings have a new and broad impact upon evaluating mechanisms of action of gene regulators at a cellular system level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17646391      PMCID: PMC2099228          DOI: 10.1128/MCB.01695-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  91 in total

Review 1.  Nuclear receptor coregulators: multiple modes of modification.

Authors:  Ola Hermanson; Christopher K Glass; Michael G Rosenfeld
Journal:  Trends Endocrinol Metab       Date:  2002-03       Impact factor: 12.015

2.  ATP-dependent release of glucocorticoid receptors from the nuclear matrix.

Authors:  Y Tang; D B DeFranco
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

Review 3.  Nuclear receptor coactivators and corepressors.

Authors:  K B Horwitz; T A Jackson; D L Bain; J K Richer; G S Takimoto; L Tung
Journal:  Mol Endocrinol       Date:  1996-10

4.  Ligand-mediated assembly and real-time cellular dynamics of estrogen receptor alpha-coactivator complexes in living cells.

Authors:  D L Stenoien; A C Nye; M G Mancini; K Patel; M Dutertre; B W O'Malley; C L Smith; A S Belmont; M A Mancini
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors.

Authors:  J J Voegel; M J Heine; C Zechel; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

6.  Steroid receptor coactivator-3 is required for inhibition of neointima formation by estrogen.

Authors:  Yuhui Yuan; Lan Liao; David A Tulis; Jianming Xu
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

7.  Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue.

Authors:  H J List; R Reiter; B Singh; A Wellstein; A T Riegel
Journal:  Breast Cancer Res Treat       Date:  2001-07       Impact factor: 4.872

8.  Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase.

Authors:  Ray-Chang Wu; Jun Qin; Yoshihiro Hashimoto; Jiemin Wong; Jianming Xu; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

9.  Microtubule-dependent subcellular redistribution of the transcriptional coactivator p/CIP.

Authors:  Majdi S Qutob; Rabindra N Bhattacharjee; Elisa Pollari; Siu Pok Yee; Joseph Torchia
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

10.  Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.

Authors:  V J Gnanapragasam; H Y Leung; A S Pulimood; D E Neal; C N Robson
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

View more
  37 in total

1.  Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity.

Authors:  Larbi Amazit; Audrey Roseau; Junaid A Khan; Anne Chauchereau; Rakesh K Tyagi; Hugues Loosfelt; Philippe Leclerc; Marc Lombès; Anne Guiochon-Mantel
Journal:  Mol Endocrinol       Date:  2011-01-27

2.  Glucocorticoid-dependent phosphorylation of the transcriptional coregulator GRIP1.

Authors:  Jana Dobrovolna; Yurii Chinenov; Megan A Kennedy; Bill Liu; Inez Rogatsky
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

3.  The myImageAnalysis project: a web-based application for high-content screening.

Authors:  Adam T Szafran; Michael A Mancini
Journal:  Assay Drug Dev Technol       Date:  2014 Jan-Feb       Impact factor: 1.738

4.  Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.

Authors:  Zeynep Madak-Erdogan; Karen J Kieser; Sung Hoon Kim; Barry Komm; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2008-07-10

5.  Variable expression of nuclear receptor coactivator 4 (NcoA4) during mouse embryonic development.

Authors:  Alexandra Kollara; Theodore J Brown
Journal:  J Histochem Cytochem       Date:  2010-03-30       Impact factor: 2.479

Review 6.  Development of subtype-selective oestrogen receptor-based therapeutics.

Authors:  Stefan Nilsson; Konrad F Koehler; Jan-Åke Gustafsson
Journal:  Nat Rev Drug Discov       Date:  2011-09-16       Impact factor: 84.694

7.  Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.

Authors:  Sudipan Karmakar; Estrella A Foster; Julia K Blackmore; Carolyn L Smith
Journal:  Endocr Relat Cancer       Date:  2010-12-21       Impact factor: 5.678

8.  The role of AIB1 in breast cancer.

Authors:  Alan K Chang; Huijian Wu
Journal:  Oncol Lett       Date:  2012-07-16       Impact factor: 2.967

9.  Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK.

Authors:  Lindsey S Treviño; Michael J Bolt; Sandra L Grimm; Dean P Edwards; Michael A Mancini; Nancy L Weigel
Journal:  Mol Endocrinol       Date:  2015-12-11

10.  Androgen receptor mutations associated with androgen insensitivity syndrome: a high content analysis approach leading to personalized medicine.

Authors:  Adam T Szafran; Sean Hartig; Huiying Sun; Ivan P Uray; Maria Szwarc; Yuqing Shen; Sanjay N Mediwala; Jennifer Bell; Michael J McPhaul; Michael A Mancini; Marco Marcelli
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.